Press Releases

Decision Resources' analysts are the leading experts on various healthcare issues. From specific drug market analysis to insights on industry trends, Decision Resources' analysts are available to speak with journalists on almost any topic.

For media inquiries or to speak with an analyst, please contact:

Elizabeth Marshall
+1-781-296-2563
emarshall@dresources.com

Press Release Archive

2008

LAUNCH OF TARGETED AGENTS AND INCREASED USE OF MAINTENANCE THERAPY WILL DRIVE THE NON-SMALL-CELL LUNG CANCER DRUG MARKET TO NEARLY TRIPLE TO ALMOST $10 BILLION IN 2018

June 29, 2009

Emerging Agents from Pfizer, AstraZeneca, GlaxoSmithKline, Bayer/Onyx and Boehringer Ingelheim, and Increased Use of Existing Agents from Eli Lilly and Roche Will Drive Growth, According to a New Report from Decision Resources

Read More
AVAILABILITY IN BOTH INTRAVENOUS AND ORAL FORMULATION IS A LEADING DRUG ATTRIBUTE SURVEYED PHYSICIANS PREFER FOR THE TREATMENT OF URINARY TRACT INFECTIONS IN THE HOSPITAL SETTING

June 24, 2009

Seventy-Seven Percent of Surveyed Physicians Will Increase Their Use of Carbapenems In the Next Five Years, According to a New Report from AMR and Decision Resources

Read More
AN INCREASE IN THE DIAGNOSED PREVALENT POPULATION WILL DRIVE GROWTH OF NEARLY $4.3 BILLION IN THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET

June 23, 2009

Emerging Combination Products from GlaxoSmithKline/Theravance, Boehringer Ingelheim and Novartis Will Drive Growth, According to a New Report from Decision Resources

Read More
HEPATITIS C VIRUS MARKET WILL EXPAND DRAMATICALLY FROM $2 BILLION IN 2008 TO NEARLY $7.7 BILLION IN 2013

June 22, 2009

Roche and Schering-Plough Will Continue to be Prominent Players in the Market, According to a New Report from Decision Resources

Read More
SEROQUEL’S FIRST- AND SECOND-LINE PATIENT SHARE HAS GROWN SINCE LAST YEAR’S ANALYSIS OF PRESCRIBING TRENDS IN BIPOLAR DISORDER

June 22, 2009

Although Risperidone Is Now Available In Generics, There Is No Clear Evidence of Expanded Uptake in Early Lines of Therapy, According to a New Report from Decision Resources

Patient-Flow Forecasts Need to Take Into Account Shifts in Seroquel XR’s Use by Line of Therapy Over the Next Two Years

Read More
NEW THERAPIES, INCLUDING NOVEL BIOLOGIC AGENTS FROM ELAN/WYETH AND ELI LILLY, WILL DRIVE ROBUST 11 PERCENT ANNUAL GROWTH IN THE ALZHEIMER’S DISEASE MARKET

June 17, 2009

Sales of Acetylcholinesterase Inhibitors, Which Currently Dominate the Market, Will Decline by $1 Billion from 2008 to 2018, According to a New Report from Decision Resources

Read More
DESPITE GENERIC EROSION OF KEY BRANDS, THE HOSPITAL-ACQUIRED GRAM NEGATIVE INFECTIONS DRUG MARKET WILL INCREASE BY $1 BILLION FROM 2008 TO 2018

June 16, 2009

Uptake of Novel Agents from Novexel, Johnson & Johnson and Wyeth Will Drive Growth, According to a New Report from Decision Resources

Read More
GROWTH IN THE PARKINSON’S DISEASE DRUG MARKET, FUELED BY THE LAUNCH OF SEVERAL NEW THERAPIES, WILL BE OFFSET BY GENERIC EROSION OF KEY AGENTS

June 9, 2009

Overall Market Will Increase by a Modest $300 Million From 2008 to 2018, According to a New Report from Decision Resources

Read More
GENERIC EROSION, INCREASED COMPETITION AND COST CONSCIOUSNESS WILL REDUCE OVERALL ASTHMA DRUG MARKET BY $1.8 BILLION FROM 2008 TO 2018

June 8, 2009

Principal Factor Driving the Market Decline Will be Singulair’s Loss of Brand Exclusivity, According to a New Report from Decision Resources

Read More
SURVEYED PSYCHIATRISTS AND PCPs EXPECT TO INCREASE THEIR FIRST-LINE USE OF SNRIs OVER THE NEXT TWO YEARS FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER

June 2, 2009

Only 41 Percent of Newly Diagnosed Patients Receive a Drug Within One Year of Their First Diagnosis, According to a New Report from Decision Resources

Patient-Flow Models Need to Take Into Account Effexor XR’s More Frequent Use in Early Lines of Therapy Compared With Cymbalta

Read More

Displaying results 1-10 (of 204)

|< < 1 2 3 4 5 6 7 8 9 10 > >|

Search Reports

Filter results:

Press Releases

Search Reports

News & Events